Abbott Labs opened an R&D facility in Singapore's Biopolis research park, the company’s first research lab in Southeast Asia. The new lab will conduct stability studies, supporting regulatory requirements for new products around the world. The company said it would concentrate on drugs in the areas of neuroscience and cancer. More details...
Stock Symbol: (NYSE: ABT)